Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;10(6):100579.
doi: 10.1016/j.esxm.2022.100579. Epub 2022 Nov 1.

Pooled Analysis Confirms Flibanserin's Unimpressive Efficacy, Raises Measurement Questions: A Commentary on Simon et al

Affiliations

Pooled Analysis Confirms Flibanserin's Unimpressive Efficacy, Raises Measurement Questions: A Commentary on Simon et al

Glen I Spielmans. Sex Med. 2022 Dec.
No abstract available

PubMed Disclaimer

References

    1. Simon JA, Clayton AH, Goldstein I, et al. Effects of flibanserin on subdomain scores of the Female Sexual Function Index in women with hypoactive sexual desire disorder. Sex Med. 2002;10 - PMC - PubMed
    1. Cohen J. 2nd Edition. Erlbaum; 1988. Statistical Power Analysis for the Behavioral Sciences.
    1. Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5:e45. - PMC - PubMed
    1. Simon JA, Clayton AH, Kim NN, et al. Clinically meaningful benefit in women with hypoactive sexual desire disorder treated with flibanserin. Sex Med. 2022;10 - PMC - PubMed
    1. Revicki DA, Margolis MK, Bush EN, et al. Content validity of the Female Sexual Function Index (FSFI) in pre-and postmenopausal women with hypoactive sexual desire disorder. J Sex Med. 2011;8:2237–2245. doi: 10.1111/j.1743-6109.2011.02312.x. - DOI - PubMed